A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

NCT06887933 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms

Interventions

DRUG: Niraparib

Sponsor

GlaxoSmithKline